Use of Ave5026 for minimizing the incidence of bleedings during an antithrombotic treatment

Details for Australian Patent Application No. 2008255191 (hide)

Owner Sanofi-Aventis

Inventors Destree, Dominique

Agent A J Park

Pub. Number AU-A-2008255191

Filing date 9 December 2008

Wipo publication date 24 June 2010

International Classifications

A61K 31/727 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

8 January 2009 Complete Application Filed

24 June 2010 Application Open to Public Inspection

  Published as AU-A-2008255191

24 June 2010 Corrigenda

  Complete Applications Filed - Name Index Under the name Sanofi-Aventis, Application No. 2008255191, under INID (54) correct the title to read Use of Ave5026 for minimizing the incidence of bleedings during an antithrombotic treatment

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008255192-Detection of a biomarker of aberrant cells of neuroectodermal origin in a body fluid

2008255190-A method for constraining layouts